Cancer clinical trials in the region Hauts-de-France

162 currently recruiting clinical trials
Region Hauts-de-France

Phase 3 Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
Hôpital Albert Calmette de Lille (Lille)
Genmab
Phase 3 Lymphoma
#NCT06508658
B cell lymphoma Large B cell lymphoma None CD20 Chemotherapy Monoclonal antibodies
Systemic Treatment-Naive Bispecific T-cell engager antibodies
Hôpital Saint Vincent-De-Paul (Lille)
Genmab
Phase 3 Stomach and esophageal cancer
#NCT06346392
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 1 2 3 or more Chemotherapy
HER2 Systemic Treatment-Naive
Hôpital Claude Huriez (Lille)
AstraZeneca
Phase 3 Lymphoma CLL & Richter's syndrome
#NCT06428019
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma > 60 ml/min 50-60 ml/min 30-50 ml/min Systemic Treatment-Naive
CHU Amiens-Picardie (Amiens)
Abbvie
Phase 3 CLL & Richter's syndrome
#NCT05947851
CLL (Chronic Lymphocytic Leukemia) None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Hôpital Claude Huriez (Lille)
Merck Sharp & Dohme LLC
Phase 3 Lymphoma
#NCT05947851
B cell lymphoma Lymphocytic lymphoma None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
Hôpital Claude Huriez (Lille)
Merck Sharp & Dohme LLC
Phase 3 Lymphoma
#NCT05605899
B cell lymphoma Large B cell lymphoma None None Systemic Treatment-Naive
Hôpital Claude Huriez (Lille)
Kite, A Gilead Company
Phase 3 Breast cancer
#NCT05512364
HER2 Negative HR Positive Locally Advanced Hormone therapy Hormone therapy
Centre de radiothérapie Pierre Curie (Beuvry), Centre Hospitalier de Boulogne-sur-Mer (Boulogne-sur-Mer)
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3 Lung cancer
#NCT06840782
NSCLC (Non-Small Cell Lung Cancer) Metastatic None
ALK EGFR ROS-1
Groupe Hospitalier Public du Sud de l'Oise (Creil)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Lung cancer
#NCT06623422
NSCLC (Non-Small Cell Lung Cancer) Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
ALK EGFR Immunotherapy Immunotherapy
Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
Merck Sharp & Dohme LLC